Pharmaceutical Analysis of Berberine: An Update

Preeti S. Bobade,Saurabh B. Ganorkar,Pragati N. Baviskar,Nikita B. Patil,Dhananjay B. Shinde,Atul A. Shirkhedkar,Shailesh S. Chalikwar
DOI: https://doi.org/10.1080/15422119.2024.2423403
2024-11-27
Separation and Purification Reviews
Abstract:The benzylisoquinoline alkaloid Berberine (BER) is a crucial phytopharmaceutical. The present review focuses on the precise analytical BER profile. The accurate BER estimation as a drug along with other drugs and in plant extracts, biological tissues/homogenates, and pharmaceutical formulations needs updates for precise and comparative analytical profiles. This is due to the versatile BER therapeutic explorations. A crucial focus has been given to analytical perquisites, pharmacopoeial status, pharmacokinetics, and toxicity. Methods for estimation of BER as individual bulk drug (natural product) are described along with simultaneous analytical and bioanalytical estimations in mixtures. Chromatography, spectroscopy and other atypical methods are presented concisely with analytical characteristics and purposes with statistics on their relative use. A tentatively complete, comparative, and precise update about the pharmaceutical analytical profile for BER is presented. To conclude, it was pointed that BER still awaits forced degradation studies, the use of statistical/experimental design, analytical quality by design approaches, and bioanalytical methods that were found to be limited to plasma and urine. This article may serve as a guideline for future analytical investigations for BER to assist in drug discovery approaches and formulation research.
engineering, chemical,chemistry, analytical, applied
What problem does this paper attempt to address?